文献速递神经肿瘤功能神经外科

胶质瘤遗传图谱与电生理过度兴奋相关

Glioma genetic profiles associated with electrophysiologic hyperexcitability.
PubMed 文献 · Neuro Oncol · 2024-01-01

单中心队列分析1716例WHO 1-4级胶质瘤成人患者的靶向外显子测序,并与经验证的脑电图数据库交叉比对,识别出206例接受连续脑电图监测者;过度兴奋定义为存在侧化周期性放电和/或脑电发作。仅基于复发性体细胞突变的交叉验证判别分析模型识别过度兴奋的总体准确率为70.9%,该突变谱在控制年龄、性别、肿瘤位置、整合病理诊断、复发状态和术前癫痫的多变量分析中改善了过度兴奋的估计。

要点

  • ATRX、TP53无义突变,RBBP8、CREBBP插入缺失突变,以及EGFR、KRAS、PIK3CA、TP53、USP28预测有害的非同义错义突变与过度兴奋相关。
  • 基于复发性体细胞突变的判别分析模型识别脑电过度兴奋的总体准确率为70.9%,无论是否纳入IDH1 R132H。
  • 有无过度兴奋患者的WHO分级分布和肿瘤突变负荷相似。

核心结论

  • 这些发现提示多种胶质瘤体细胞突变与瘤周过度兴奋相关,肿瘤遗传图谱可能有助于胶质瘤相关癫痫的预后判断和管理。

研究设计与样本

  • 单中心队列分析1716例WHO 1-4级胶质瘤成人患者的靶向外显子测序,并与经验证的脑电图数据库交叉比对,识别出206例接受连续脑电图监测者。

主要发现

  • 有无过度兴奋患者的WHO分级分布和肿瘤突变负荷相似。
  • 判别分析模型识别脑电过度兴奋的总体准确率为70.9%,无论是否纳入IDH1 R132H。
  • 预测性变异包括ATRX和TP53的无义突变、RBBP8和CREBBP的插入缺失突变,以及EGFR、KRAS、PIK3CA、TP53和USP28中预测有害的非同义错义突变。
  • 该突变谱在控制年龄、性别、肿瘤位置、整合病理诊断、复发状态和术前癫痫的多变量分析中改善了过度兴奋的估计。
  • 预测的体细胞突变变异在过度兴奋患者中较无过度兴奋者和未接受连续脑电图者更常见。

关键数值与推荐

  • 过度兴奋定义为存在侧化周期性放电和/或脑电发作。
  • 判别分析模型仅基于复发性体细胞突变训练,识别过度兴奋的总体准确率为70.9%。

临床怎么用

  • 原文结论指出肿瘤遗传图谱可能有助于胶质瘤相关癫痫的预后判断和管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Distinct genetic alterations determine glioma aggressiveness, however, the diversity of somatic mutations contributing to peritumoral hyperexcitability and seizures over the course of the disease is uncertain. This study aimed to identify tumor somatic mutation profiles associated with clinically significant hyperexcitability. METHODS: A single center cohort of adults with WHO grades 1-4 glioma and targeted exome sequencing (n = 1716) was analyzed and cross-referenced with a validated EEG database to identify the subset of individuals who underwent continuous EEG monitoring (n = 206). Hyperexcitability was defined by the presence of lateralized periodic discharges and/or electrographic seizures. Cross-validated discriminant analysis models trained exclusively on recurrent somatic mutations were used to identify variants associated with hyperexcitability. RESULTS: The distribution of WHO grades and tumor mutational burdens were similar between patients with and without hyperexcitability. Discriminant analysis models classified the presence or absence of EEG hyperexcitability with an overall accuracy of 70.9%, regardless of IDH1 R132H inclusion. Predictive variants included nonsense mutations in ATRX and TP53, indel mutations in RBBP8 and CREBBP, and nonsynonymous missense mutations with predicted damaging consequences in EGFR, KRAS, PIK3CA, TP53, and USP28. This profile improved estimates of hyperexcitability in a multivariate analysis controlling for age, sex, tumor location, integrated pathologic diagnosis, recurrence status, and preoperative epilepsy. Predicted somatic mutation variants were over-represented in patients with hyperexcitability compared to individuals without hyperexcitability and those who did not undergo continuous EEG. CONCLUSION: These findings implicate diverse glioma somatic mutations in cancer genes associated with peritumoral hyperexcitability. Tumor genetic profiling may facilitate glioma-related epilepsy prognostication and management.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Tobochnik S, Dorotan MKC, Ghosh HS, et al. Glioma genetic profiles associated with electrophysiologic hyperexcitability. Neuro Oncol. 2024. PMID: 37713468. doi:10.1093/neuonc/noad176

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。